empagliflozin
boehringer ingelheim,eli lilly
['empag', 'cardio', 'hfref', 'empagliflozin']
be sure to join 's moderated poster presentation today at 10am ct on the benefits of the sglt2 inhibitor empagliflozin on epicardial adipose tissue in non-diabetic hfref. #cardiotwitter 
An international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for @MountSinaiNYC.